Jagsonpal Pharmaceuticals share news and announcements
NSE: JAGSNPHARMBSE: 507789Pharmaceuticals & BiotechnologySmall Cap
Last close ₹211.76up ₹0.90 (0.43%)BSE ₹211.70
Share price at the NSE close on 23 Oct 2026. Previous close ₹210.86.
52-week range of traded prices to 23 Oct 2026
₹155.00Low, 22 Jan 2026₹264.50High, 30 Jun 2026
- Next results date: the board meets on 28 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,399 Cr1,360th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 30.8
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 5.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.89%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 18.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 70,16245.8% delivered
Jagsonpal Pharmaceuticals share news and announcements
547 announcements, routine notices left out, newest first. Page 10 of 11.
Oct 2015
1 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2015
Aug 2015
20 Aug · Meeting
Register of Members & Share Transfer Books of the Company shall remain closed from September 23, 2015 to September 30, 2015 (both days inclusive) for the purpose of Dividend and Annual General Meeting (AGM) of the Company to be held on September 30, 2015.
Jul 2015
Jun 2015
5 Jun · Code of Conduct under SEBI(PIT) Reg., 2015
May 2015
Apr 2015
Mar 2015
18 Mar · Management
Mrs. Jasbir Kaur Kochhar has been appointment as women Director of the Company in terms of compliance of companies Act 2013, and any other provisions if any.
Feb 2015
3 Feb · Board meeting
To Consider, approve and take on record the Un-audited Financial Results (provisional) of the Company for the quarter ended December 31, 2014.
Nov 2014
4 Nov · Board meeting
To Consider, approve and take on record the Un-audited Financial Results (provisional) of the Company for the quarter ended September 30, 2014.
Oct 2014
1 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2014
8 Sep · Corporate action
Register of Members and Share Transfer Books of the Company shall remain closed from September 27, 2014 to September 30, 2014 (both days inclusive) for the purpose of Dividend of Re. 0.50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2014 and for the purpose of Annual General Meeting.
Aug 2014
14 Aug · Board meeting
Company had informed the Exchange regarding a meeting of the Board of Directors of the Company to be held on August 14, 2014. The Company has now informed the Exchange that the aforesaid Board Meeting stand adjourned to August 21, 2014 due to want of quorum.11 Aug · Updates
August 22, 2014 as Cut off date for E-voting for the purpose of Annual General Meeting to be held on September 30, 2014.6 Aug · Board meeting
To Consider, approve and take on record the Un-audited Financial Results (provisional) of the Company for the quarter ended June 30, 2014.
May 2014
Apr 2014
28 Apr · Legal
Price movement : Significant price movement has been observed in Jagsonpal Pharmaceuticals Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Jagsonpal Pharmaceuticals Limited has vide its letter inter-alia stated,"In compliance to above we hereby confirm that NO NON Compliance / violation is from company's part. Why there is so fluctuation in share prices we don't have any information and nothing unusal / important activity has been conducted by the company."
Feb 2014
3 Feb · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended December 31, 2013.
Nov 2013
5 Nov · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended on September 30, 2013.
Oct 2013
1 Oct · Disclosure of Voting Pattern - Clause 35A
Sep 2013
4 Sep · Corporate action
Company has fixed Book Closure from September 27, 2013 to September 30, 2013 for the purpose of Dividend of Rs. .50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2013 and for the purpose of Annual General Meeting.
Aug 2013
6 Aug · Board meeting
To consider and take on record the Un-Audited financial results (Provisional) for the quarter ended June 30, 2013.
May 2013
21 May · Board meeting
To : (1) Consider and Approve the Audited Financial Results for the quarter/ year ended March 31, 2013; (2) Recommend dividend, if any, for the year ended March 31, 2013.
Apr 2013
16 Apr · Change in Company Secretary/Compliance Officer
Vide letter dated April 01, 2013 that the Company Secretary Mr. S. K. Mata, F.C.S. has resigned from his post and Mr. Raj Kaumar Kapoor has been appointed as Compliance officer cum Company Secretary w.e.f. March 20, 2013.
Feb 2013
6 Feb · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended on December 31, 2012.
Nov 2012
Oct 2012
31 Oct · Board meeting
To consider and take on record the unaudited financial results (provisional) for Quarter ended on September 30, 2012.
Sep 2012
7 Sep · Corporate action
Company has announced the Book Closure from September 25, 2012 to September 28, 2012 (Both Days Inclusive), for the purpose of Dividend of Rs. 0.50 only (Paisa Fifty only) per Equity Share of Rs. 5/- each for the Financial Year ended March 31, 2012 and for the purpose of Annual General Meeting.
Aug 2012
Jun 2012
1 Jun · Dividend
Board of Directors of the Company at its meeting held on May 30, 2012 has recommended a dividend of Rs. 0.50 per equity shares on 2,61,98,000 Equity Shares of Rs. 5/ each for the year 2011-12.
May 2012
21 May · Board meeting
To : (1) Consider and Approve the Audited Financial Results for the quarter/ year ended March 31, 2012; (2) Recommend dividend, if any, for the year ended March 31, 2012.